Olukemi Olugemo - 03 Feb 2025 Form 4 Insider Report for Korro Bio, Inc. (KRRO)

Role
Chief Medical Officer
Signature
/s/ Jeffrey Cerio, Attorney-in-fact
Issuer symbol
KRRO
Transactions as of
03 Feb 2025
Net transactions value
$0
Form type
4
Filing time
05 Feb 2025, 16:14:52 UTC
Previous filing
04 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRRO Stock Option (Right to Buy) Award $0 +42,000 $0.000000 42,000 03 Feb 2025 Common Stock 42,000 $33.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest in 48 equal monthly installments commencing from February 3, 2025, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

Exhibit 24.1 - Power of Attorney